Swiss Pharma

Ahmedabad, India Founded: 1987 • Age: 39 yrs Acquired By Covance
Injectable drugs, tablets, capsules, and pharmaceutical products are manufactured.
Annual revenue $4.6M Latest available
Total funding - Funding intelligence
Employees 50 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Swiss Pharma

Swiss Pharma is a company based in Ahmedabad (India) founded in 1987 by Sharadchandra Rasiklal Shah was acquired by Covance in March 2009. The company has 50 employees as of February 10, 2025.

  • Headquarter Ahmedabad, India
  • Employees 50 as on 10 Feb, 2025
  • Founders Sharadchandra Rasiklal Shah
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Swiss Pharma Pvt. Ltd
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.6 M (USD)
    -12.55
    as on Mar 31, 2024
  • Net Profit
    $18.74 K (USD)
    -57.53
    as on Mar 31, 2024
  • EBITDA
    $391.95 K (USD)
    -16.82
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    50

    as on Feb 10, 2025

  • Acquired by
    Covance

    (Mar 01, 2009)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Swiss Pharma

Premium access

Detailed funding history for Swiss Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Swiss Pharma

Swiss Pharma has secured backing from 1 investor. Prominent investors backing the company include Covance.

All
Investor Description Founded Year Domain Location
CRO offering comprehensive drug development solutions from drug discovery to life cycle management
Locked Locked Locked
Premium access

Investor details for Swiss Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Swiss Pharma

Investments
Premium access

Investment portfolio details for Swiss Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Swiss Pharma

Premium access

Detailed financials for Swiss Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Swiss Pharma Comparisons

Swiss Pharma Primary company
Description
Injectable drugs, tablets, capsules, and pharmaceutical prod...
Location
Ahmedabad, India
Founded Year
1987
Annual Revenue
$4.6 M (USD)
Net Profit
$18.74 K (USD)
EBITDA
$391.95 K (USD)
Employees
50
As of 2025
Premium access

Peer comparison for Swiss Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Swiss Pharma

Premium access

Detailed competitors of Swiss Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Swiss Pharma

Premium access

Complete news archive for Swiss Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swiss Pharma

Swiss Pharma was founded in 1987.

Swiss Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Darshan Shah is the current CEO of Swiss Pharma.

As of Feb 10, 2025, the latest employee count at Swiss Pharma is 50.

Annual revenue of Swiss Pharma is $4.6M as on Mar 31, 2024.

Swiss Pharma was founded in 1987 and is based in Ahmedabad, India. Operations focus on the pharmaceutical sector, where a range of products including injectable drugs, tablets, capsules, sterile items for parenteral and ophthalmic applications, Ayurvedic herbal medicines, and veterinary medicines are produced in a dedicated facility. Contract manufacturing services are also provided to other firms, addressing various pharmaceutical requirements.

Swiss Pharma has 1 investor. Key investors include Covance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available